分子诊断与治疗杂志
分子診斷與治療雜誌
분자진단여치료잡지
JOURNAL OF MOLECULAR DIAGNOSIS AND THERAPY
2013年
6期
367-370
,共4页
成彩联%郑振达%石成钢%叶增纯%李灿明%娄探奇
成綵聯%鄭振達%石成鋼%葉增純%李燦明%婁探奇
성채련%정진체%석성강%협증순%리찬명%루탐기
晚期糖基化终产物%足细胞%α-actinin-4
晚期糖基化終產物%足細胞%α-actinin-4
만기당기화종산물%족세포%α-actinin-4
Advanced glycation end-products%Podocyte%α-actinin-4
目的观察晚期糖基化终产物(AGEs)对足细胞α-actinin-4的影响及氯沙坦的干预作用。方法不同浓度的AGEs(0,20,40,80μg/mL)干预足细胞24 h后,采用免疫印迹法检测足细胞α-actinin-4的表达。通过激光共聚焦显微镜观察足细胞肌动蛋白F-actin和α-actinin-4的分布,并在氯沙坦预处理足细胞后,观察α-actinin-4和F-actin的改变。结果与对照组相比,AGEs(80μg/mL)可明显降低足细胞α-actinin-4的表达[(62±13)%vs.100%,P<0.05],使α-actinin-4由膜周分布转为核周分布,并使肌动蛋白F-actin发生重构,而氯沙坦预处理可减轻AGEs介导的α-actinin-4的下调[(80±14)%vs.(62±13)%,P<0.05]和α-actinin-4和F-actin的重构,P<0.05。结论 AGEs可下调α-actinin-4表达,介导骨架蛋白的重构,而氯沙坦可减轻AGEs介导的这些改变。
目的觀察晚期糖基化終產物(AGEs)對足細胞α-actinin-4的影響及氯沙坦的榦預作用。方法不同濃度的AGEs(0,20,40,80μg/mL)榦預足細胞24 h後,採用免疫印跡法檢測足細胞α-actinin-4的錶達。通過激光共聚焦顯微鏡觀察足細胞肌動蛋白F-actin和α-actinin-4的分佈,併在氯沙坦預處理足細胞後,觀察α-actinin-4和F-actin的改變。結果與對照組相比,AGEs(80μg/mL)可明顯降低足細胞α-actinin-4的錶達[(62±13)%vs.100%,P<0.05],使α-actinin-4由膜週分佈轉為覈週分佈,併使肌動蛋白F-actin髮生重構,而氯沙坦預處理可減輕AGEs介導的α-actinin-4的下調[(80±14)%vs.(62±13)%,P<0.05]和α-actinin-4和F-actin的重構,P<0.05。結論 AGEs可下調α-actinin-4錶達,介導骨架蛋白的重構,而氯沙坦可減輕AGEs介導的這些改變。
목적관찰만기당기화종산물(AGEs)대족세포α-actinin-4적영향급록사탄적간예작용。방법불동농도적AGEs(0,20,40,80μg/mL)간예족세포24 h후,채용면역인적법검측족세포α-actinin-4적표체。통과격광공취초현미경관찰족세포기동단백F-actin화α-actinin-4적분포,병재록사탄예처리족세포후,관찰α-actinin-4화F-actin적개변。결과여대조조상비,AGEs(80μg/mL)가명현강저족세포α-actinin-4적표체[(62±13)%vs.100%,P<0.05],사α-actinin-4유막주분포전위핵주분포,병사기동단백F-actin발생중구,이록사탄예처리가감경AGEs개도적α-actinin-4적하조[(80±14)%vs.(62±13)%,P<0.05]화α-actinin-4화F-actin적중구,P<0.05。결론 AGEs가하조α-actinin-4표체,개도골가단백적중구,이록사탄가감경AGEs개도적저사개변。
Objective To investigate the effects of advanced glycation end-products (AGEs) on the expression of α-actinin-4 and their mechanism. Methods Podocytes were incubated with different concentrations of AGEs for 24 hours, and the expression levels of α-actinin-4 were measured by western blot. The arrangement of α-actinin-4 and F-actin were observed by laser scanning confocal microscopy. Then podocytes were pretreated with losartan for 60 min before AGEs added. The changes of α-actinin-4 and cytoskeleton were observed. Results Incubation with AGEs (80μg/mL) resulted in a significant decrease in the expression ofα-actinin-4 [(62±13)%vs. 100%, P<0.05], AGEs (80μg/mL) also induced bothα-actinin-4 and F-actin rearrangement. However, pretreatment with losartan (100 μmol/L) prevented the effects induced by AGEs in podocytes. Conclusion AGEs downregulate α-actinin-4 expression and induce cytoskeleton reorganization, and losartan prevent the changes induced by AGEs.